Washington state will receive $7 million from multistate settlements with Abbott Laboratories over allegations the company illegally promoted an anti-seizure drug.
Abbott has agreed to pay $1.5 billion over the illegal off-label marketing of its anti-seizure drug Depakote.
A total of 49 states, plus the District of Columbia, are participating in the Medicaid settlement announced Monday. Washington state Attorney General Rob McKenna says the state is to receive $10 million from that, but half of that amount goes to the federal government, netting the state $5 million. The state will receive an additional $2 million under a separate settlement with Abbott of consumer claims in 45 states and the District of Columbia. The consumer claims over Abbott's promotion of Depakote for unapproved uses were brought under the Virginia Consumer Protection Act.
Depakote is an anti-seizure and mood-stabilizing drug prescribed for bipolar disorder.